Aspirin augmentation of the efficacy of thrombolysis.
O'Donnell
C J
CJ
Division of Preventive Medicine, Brigham and Women's Hospital, Cardiology Section, Boston MA 02215, USA.
Jonas
M A
MA
Hennekens
C H
CH
D001241:Aspirin / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D013300:Streptokinase; D001241:Aspirin